Farhad Hafezi

Corneal Physician reports on ELZA's exploration of slit-lamp CXL as a promising, accessible treatment for infectious keratitis.

ELZA-PACE not only improves corneal biomechanics (just like regular CXL) but by flattening the cone significantly, also enhances patients' visual quality. The results so far indicate that patients treated with this method have better visual outcomes compared to traditional CXL treatments.

The Ophthalmologist's "CXL: What's New in 2023?" article explores advancements in corneal collagen crosslinking for treating keratoconus. ELZA's Farhad Hafezi discusses how CXL has advanced to the current state of the art, and highlights new breakthroughs like sub400 and PACE.